WHO and African Medicines Agency Join Forces to Transform Healthcare Access Across Africa
Geneva, May 2025 — In a landmark move to improve healthcare access and safety, the World Health Organization (WHO) and the newly established African Medicines Agency (AMA) have signed a major collaboration agreement. The deal, finalized during the 79th World Health Assembly, aims to streamline drug regulations, combat counterfeit medicines, and accelerate approvals for life-saving treatments across the continent.
A Unified Push for Safer, Faster Healthcare
Africa has long struggled with fragmented drug regulations, slow approval processes, and a flood of substandard or fake medicines. The new partnership seeks to change that by harmonizing standards, boosting local production, and strengthening oversight.
“Strong regulations save lives,” said Dr. Yukiko Nakatani, WHO Assistant Director-General. “This agreement is a turning point—not just for Africa, but for global health security.”
Why This Matters for African Patients
For millions in Africa, accessing safe, effective medicines remains a challenge. Delays in approvals, inconsistent standards, and weak enforcement have left many vulnerable to counterfeit drugs. The AMA, backed by the African Union, was created to tackle these issues.
“Every African deserves confidence that their medicines are safe and effective,” said Dr. Delese Mimi Darko, AMA Director-General. “This partnership with WHO will help us build trust, cut red tape, and get treatments to people faster.”
Key Goals of the Agreement
The WHO-AMA plan focuses on:
- Faster drug approvals by reducing duplicate reviews across countries.
- Cracking down on fake medicines through better surveillance.
- Training regulators to improve oversight and compliance.
- Boosting African drug manufacturing to reduce reliance on imports.
- Preparing for health crises with faster emergency responses.
A Model for the World?
Beyond Africa, the AMA could set a precedent for regional cooperation in drug regulation. By aligning standards and sharing resources, African nations hope to create a more efficient system that attracts investment and ensures quality care.
“Success isn’t just about creating an agency—it’s about delivering real results: safer drugs, quicker access, and stronger health systems,” said Dr. Mohamed Yakub Janabi, WHO Regional Director for Africa.
What’s Next?
The agreement sets a 3-5 year roadmap, with governments urged to ratify the AMA treaty and invest in regulatory reforms. Health ministers, AU leaders, and global partners gathered at the WHO assembly to pledge support.
As Africa moves toward a unified regulatory framework, the world will be watching—and patients stand to gain the most.
— Reported by Nexio News
